How Much Did BioLargo Raise?
Funding & Key Investors

BioLargo, Inc. has secured $6.3M in total capital, with its most recent funding round bringing in $150K through a major strategic investment. This latest financing underscores the company's significant progress and its position within the enterprise technology sector.

What is BioLargo?

BioLargo
ManufacturingChemicals & Related ProductsBusiness Services

BioLargo, Inc. is a technology-driven company specializing in innovative solutions for critical industries including wastewater treatment, food processing, healthcare, agriculture, and oil and gas. The company's proprietary technologies, such as Advanced Oxidation System (AOS), CupriDyne, and Isan system, are designed to address complex challenges in disinfection, water purification, and odor control. BioLargo markets a range of commercial, household, and personal care products under established brand names like Odor-No-More, Natures Best Solution, Deodorall, and NBS, demonstrating a broad application of its core technological advancements. Founded in 1989 and based in Westminster, BioLargo has evolved its offerings to meet diverse market needs.

How much funding has BioLargo raised?

BioLargo has raised a total of $6.3M across 8 funding rounds:

2008

Debt

$723K

2009

Debt

$681K

2010

Debt

$1.1M

2011

Debt

$978K

2012

Debt

$1.1M

2013

Debt

$700K

Debt

$862K

2020

Debt

$150K

Debt (2008): $723K, investors not publicly disclosed

Debt (2009): $681K, investors not publicly disclosed

Debt (2010): $1.1M, investors not publicly disclosed

Debt (2011): $978K, investors not publicly disclosed

Debt (2012): $1.1M, investors not publicly disclosed

Debt (2013): $700K, investors not publicly disclosed

Debt (2013): $862K, investors not publicly disclosed

Debt (2020): $150K supported by PPP

What's next for BioLargo?

The recent major strategic investment signifies a pivotal moment for BioLargo, likely enabling the company to accelerate its product development, expand market reach, and scale its operations. This capital infusion is expected to bolster its efforts in commercializing its advanced oxidation and disinfection technologies across its target sectors. The company's focus on essential industries such as water treatment and healthcare positions it for sustained growth and impact, leveraging its technological edge to address growing environmental and health concerns.

See full BioLargo company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & EquipmentRetailApparel & Accessories RetailTextiles & Apparel
ManufacturingTelecommunication Equipment
Industrial Machinery & EquipmentManufacturingAutomotive Parts
Food & BeverageManufacturingConsumer ServicesPhotography Studio

Frequently Asked Questions Regarding BioLargo Financial Insights

What are the most recent funding rounds that BioLargo has completed, and what were the funding rounds?
BioLargo has recently completed 3 funding rounds: Debt on Jun 30, 2020, Debt on Sep 2, 2013, Debt on Feb 25, 2013.
What is the total amount of funding BioLargo has raised to date?
BioLargo has raised a total of $6.3M in funding to date.
How many funding rounds has BioLargo completed?
BioLargo has completed 3 funding rounds.
How much funding did BioLargo raise in its most recent funding round?
BioLargo raised $150K in its most recent funding round.
Who are the lead investors in BioLargo's latest funding round?
The lead investor in BioLargo's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in BioLargo's history?
The largest funding round in BioLargo's history was $1.1M.
See more information about BioLargo